These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28878257)

  • 1. Molecular mechanisms governing microRNA-125a expression in human hepatocellular carcinoma cells.
    Potenza N; Panella M; Castiello F; Mosca N; Amendola E; Russo A
    Sci Rep; 2017 Sep; 7(1):10712. PubMed ID: 28878257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutual suppression of miR-125a and Lin28b in human hepatocellular carcinoma cells.
    Panella M; Mosca N; Di Palo A; Potenza N; Russo A
    Biochem Biophys Res Commun; 2018 Jun; 500(3):824-827. PubMed ID: 29689270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf.
    Coppola N; de Stefano G; Panella M; Onorato L; Iodice V; Minichini C; Mosca N; Desiato L; Farella N; Starace M; Liorre G; Potenza N; Sagnelli E; Russo A
    Oncotarget; 2017 Apr; 8(15):25289-25299. PubMed ID: 28445974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-125a-5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells.
    Potenza N; Mosca N; Zappavigna S; Castiello F; Panella M; Ferri C; Vanacore D; Giordano A; Stiuso P; Caraglia M; Russo A
    J Cell Physiol; 2017 Jul; 232(7):1907-1913. PubMed ID: 27982429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proto-oncogene Zbtb7a represses miR-125a-5p transcription in hepatocellular carcinoma cells.
    Di Palo A; Siniscalchi C; Mosca N; Russo A; Potenza N
    Mol Biol Rep; 2020 Jun; 47(6):4875-4878. PubMed ID: 32410140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
    Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW
    Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
    Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN
    Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC.
    Xu J; Wang Y; Zhang Y; Dang S; He S
    Biomed Pharmacother; 2018 Nov; 107():1682-1691. PubMed ID: 30257386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZEB1 causes the production of hsa-microRNA-99b/let-7e/microRNA-125a cluster and promotes invasion of liver cancer cells.
    Wang XF; Liu JY; Li JL; Wang FZ; Sun BL
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1468-1475. PubMed ID: 30840268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.
    Zekri AN; El-Sisi ER; Youssef ASE; Kamel MM; Nassar A; Ahmed OS; El Kassas M; Barakat AB; Abd El-Motaleb AI; Bahnassy AA
    PLoS One; 2018; 13(3):e0193709. PubMed ID: 29534065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1.
    Cao L; Xie B; Yang X; Liang H; Jiang X; Zhang D; Xue P; Chen D; Shao Z
    PLoS One; 2015; 10(7):e0133074. PubMed ID: 26177288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma.
    Jin F; Wang Y; Zhu Y; Li S; Liu Y; Chen C; Wang X; Zen K; Li L
    Sci Rep; 2017 Jun; 7(1):3089. PubMed ID: 28596599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2.
    Qin X; Wan Y; Wang S; Xue M
    Drug Des Devel Ther; 2016; 10():71-9. PubMed ID: 26766902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.
    Zeng C; Wang R; Li D; Lin XJ; Wei QK; Yuan Y; Wang Q; Chen W; Zhuang SM
    Hepatology; 2010 Nov; 52(5):1702-12. PubMed ID: 21038412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel ceRNA Regulatory Network Involving the Long Non-Coding Antisense RNA SPACA6P-AS, miR-125a and its mRNA Targets in Hepatocarcinoma Cells.
    Di Palo A; Siniscalchi C; Mosca N; Russo A; Potenza N
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-361-5p Inhibits Cancer Cell Growth by Targeting CXCR6 in Hepatocellular Carcinoma.
    Sun JJ; Chen GY; Xie ZT
    Cell Physiol Biochem; 2016; 38(2):777-85. PubMed ID: 26872014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells.
    He J; Zhao K; Zheng L; Xu Z; Gong W; Chen S; Shen X; Huang G; Gao M; Zeng Y; Zhang Y; He F
    Mol Cancer; 2015 Aug; 14():163. PubMed ID: 26302777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
    Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
    Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis.
    Chen S; Pu J; Bai J; Yin Y; Wu K; Wang J; Shuai X; Gao J; Tao K; Wang G; Li H
    J Exp Clin Cancer Res; 2018 Jan; 37(1):3. PubMed ID: 29316949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.